In Brief: Schering-Plough's Correctol
This article was originally published in The Tan Sheet
Schering-Plough's Correctol: Company running informational TV ads highlighting the fact the OTC laxative brand does not contain phenolphthalein. The national ads, designed by New York City-based Messner, Vetere, Berger, McNamee, Schmetterer/Euro RSCG, include "an important message from Correctol for every woman who uses a laxative." The ad continues: "Most Ex-lax products are being withdrawn from the market" because FDA has proposed a ban on phenolphthalein, "the active ingredient found in most Ex-lax products." The "safe alternative" is Correctol, the ad says, containing the "number one doctor recommended ingredient" (a super flashes "among stimulant laxatives"). Correctol is "Still gentle. Still effective. Still safe," the ad concludes, with the super: "Use as directed"...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Sign in to continue reading.
Need a specific report?
1000+ reports available
New to Pink Sheet?
Start a free trial today!
Register for our free email digests: